Periodic Reporting for period 1 - IronKiller (Joining the forces of Natural Killer Cells and Ferroptosis to treat Refractory Neuroblastoma)

Neuroblastoma is the most common extracranial paediatric solid tumour, and it accounts for over 15% of cancer childhood deaths. High-risk patients undergo extensive multimodal treatment, but relapse/progression rates remain over 70%. In the last decade, the use of cell...